A61K 31/573
Substituted in position 21
Official title: substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
A61K31/573 (Substituted in position 21) appears on 3,032 US grants and 6,391 published applications in this corpus.
Search patents in A61K- Granted patents
- 3,032
- Published applications
- 6,391
- Assignees
- 2,160
- Inventors
- 8,706
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 2 | 0 |
| 1993 | 3 | 0 |
| 1994 | 3 | 0 |
| 1995 | 3 | 0 |
| 1996 | 7 | 0 |
| 1997 | 26 | 0 |
| 1998 | 26 | 0 |
| 1999 | 27 | 0 |
| 2000 | 25 | 0 |
| 2001 | 29 | 12 |
| 2002 | 27 | 44 |
| 2003 | 28 | 122 |
| 2004 | 23 | 115 |
| 2005 | 20 | 132 |
| 2006 | 25 | 163 |
| 2007 | 31 | 171 |
| 2008 | 25 | 145 |
| 2009 | 21 | 175 |
| 2010 | 55 | 159 |
| 2011 | 71 | 202 |
| 2012 | 98 | 225 |
| 2013 | 96 | 231 |
| 2014 | 184 | 322 |
| 2015 | 176 | 338 |
| 2016 | 169 | 334 |
| 2017 | 216 | 368 |
| 2018 | 223 | 353 |
| 2019 | 201 | 381 |
| 2020 | 216 | 352 |
| 2021 | 185 | 371 |
| 2022 | 171 | 369 |
| 2023 | 156 | 416 |
| 2024 | 164 | 357 |
| 2025 | 188 | 283 |
| 2026 | 106 | 251 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Nanostructure or microstructure and method for producing same6 Oct 2026US 12,751,923 B2The University of Tokyo
- Compositions and methods of treating lupus nephritis6 Oct 2026US 12,752,005 B2Genentech, Inc.
- Methods of treating fibrotic liver diseases or conditions with indeglitazar29 Sep 2026US 12,746,225 B2Pleiogenix Inc.
- Method of treating SCLC and managing neutropenia29 Sep 2026US 12,746,240 B2Pharma Mar, S. A.
- Ensifentrine for decreasing the frequency/severity of COPD exacerbations15 Sep 2026US 12,734,139 B2Verona Pharma PLC
- Prolyl hydroxylase domain-containing protein (phd) inhibitors, combinations and uses thereof8 Oct 2026US 2026/0306471 A1Insilico Medicine IP Limited
- Inhaled statins as bronchodilators to improve lung function in respiratory diseases8 Oct 2026US 2026/0306477 A1Beth Israel Deaconess Medical Center, Inc.
- Compositions and methods for the treatment of congenital adrenal hyperplasia8 Oct 2026US 2026/0306485 A1Crinetics Pharmaceuticals, Inc.
- Misoprostol formulation for non-oral administration8 Oct 2026US 2026/0306508 A1Conceptra Biosciences, LLC
- Topical composition8 Oct 2026US 2026/0306512 A1Api Corporation
Most cited
By later US patents
- Method of treating androgen independent prostate cancer1,091US 9,040,574 B2Natrogen Therapeutics International, Inc. · 2015
- Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione after stem cell transplantation733US 9,101,621 B2Celgene Corporation · 2015
- Method for treating and/or preventing retinal diseases with sustained release corticosteroids323US 6,217,895 B1Control Delivery Systems, Inc. · 2001
- Method for treating and/or preventing retinal diseases with sustained release corticosteroids291US 6,548,078 B2Control Delivery Systems, Inc. · 2003
- Pharmaceutical and cosmetic carrier or composition for topical application284US 6,911,211 B2Foamix Ltd. · 2005